AW

Azra Waseem

Active Director Director DIN 07814884
DIN 07814884 First appointment Jun 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2017
Shareholding value •••• Premium profile

About Azra Waseem

Data last updated:

Azra Waseem is a Director at Wasazra Pharmaceuticals Limited (since 2017). The company operates in Trading. Wasazra Pharmaceuticals Limited reported revenue of ₹6.46 Cr (FY 2024).

DIN 07814884
Primary Designation Director
Industry Trading
First Appointment 01 Jun 2017
Oldest Company Age 9 yrs
Largest company Wasazra Pharmaceuticals Limited · ₹6.46 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wasazra Pharmaceuticals Limited U51909UP2017PLC093735
Director01 Jun 20172017₹6.46 Cr (FY 2024)Active

Board colleagues of Azra Waseem

Directorship timeline

Open interactive timeline →
Wasazra Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Azra Waseem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Azra Waseem

Azra Waseem currently holds 1 directorship: Wasazra Pharmaceuticals Limited (Director, since 01 Jun 2017, revenue ₹6.46 Cr (FY 2024)).

Azra Waseem was first appointed on 01 Jun 2017 as Director at Wasazra Pharmaceuticals Limited.

The current boards of Azra Waseem's companies include Firdaus Fatima (Wasazra Pharmaceuticals Limited), Nida Fatima (Wasazra Pharmaceuticals Limited), Sayed Ahmad Masood Hashmi (Wasazra Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available